β1-Integrin-Mediated Uptake of Chondrocyte Extracellular Vesicles Regulates Chondrocyte Homeostasis

Osteoarthritis (OA) is the most prevalent age-related degenerative disorder, which severely reduces the quality of life of those affected. Whilst management strategies exist, no cures are currently available. Virtually all joint resident cells generate extracellular vesicles (EVs), and alterations in chondrocyte EVs during OA have previously been reported. Herein, we investigated factors influencing chondrocyte EV release and the functional role that these EVs exhibit. Both 2D and 3D models of culturing C28I/2 chondrocytes were used for generating chondrocyte EVs. We assessed the effect of these EVs on chondrogenic gene expression as well as their uptake by chondrocytes. Collectively, the data demonstrated that chondrocyte EVs are sequestered within the cartilage ECM and that a bi-directional relationship exists between chondrocyte EV release and changes in chondrogenic differentiation. Finally, we demonstrated that the uptake of chondrocyte EVs is at least partially dependent on β1-integrin. These results indicate that chondrocyte EVs have an autocrine homeostatic role that maintains chondrocyte phenotype. How this role is perturbed under OA conditions remains the subject of future work.

Abstract P2-03-04: A novel druggable target upstream of Notch: MEK5/ERK5 signaling regulates Jagged-1 and Notch1 expression in triple negative breast cancer stem cells

Triple negative breast cancer (TNBC) is a molecularly heterogeneous, clinically aggressive disease group that is highly prevalent among African-Americans and younger patients. Standard chemo/radio therapy often produces clinical responses, but recurrence and metastasis are unfortunately common. Metastatic disease is generally incurable. Chemo/radiotherapy has been shown to induce EMT and enrich a chemo-resistant cancer stem-like cell (CSC) population in TNBC. CSCs are thought to drive disease recurrence. Notch signaling is critical for maintenance of TNBC CSC. Expression of Notch1 and its ligand Jagged1 are correlated with poor prognosis. Efforts to pharmacologically target Notch with Gamma Secretase Inhibitors (GSIs) have been impaired by the systemic toxicity of the GSIs, and by the fact that Notch1 also plays a key role in anti-tumor adaptive immunity. Therapeutic agents that indirectly and selectively target Notch signaling in breast cancer cells would be a potentially attractive strategy. However, no such agents have been identified to date. We have found that the MAPK5-ERK5 kinase pathway, which contains at least two druggable targets, functions as a master regulator of Notch signaling in TNBC cells. ERK5 knockout TNBC cells have dramatically decreased expression of Notch receptors, ligands and transcriptional targets. In vivo, these cells form barely detectable tumors that do not metastasize and express lower levels of Notch1 and its ligand Jagged1. Using in silico screening, we identified a class of compounds that selectively target MAP2K5 (MEK5) and decrease the phosphorylation of MAPK7 (ERK5). We selected compound SC-181 for further study. Consistent with ERK5KO cells, pharmacological suppression of ERK5 phosphorylation with SC-181 decreased Notch1 and Jagged1 mRNAs and proteins. SC-181 reversed EMT and reduced the CD44hi/CD24lo CSC population in TNBC cells, but had no effect on T-cell proliferation. SC-181 decreased the number and size of mammospheres in a concentration-dependent manner. Overexpression of the Notch1 intracellular domain (N1IC) in ERK5KO cells rescues their phenotype, dramatically increasing the CSC fraction and promoting EMT. Our results suggest that targeting the MEK5-ERK5 pathway is a promising new strategy to selectively modulate Notch signaling in TNBC CSC without compromising tumor immunity.

Citation Format: Ucar DA, Matossian MD, Hoang-Barnes VT, Hossain FM, Gupta M, Burks HE, Wright TD, Cavanaugh J, Flaherty P, Burow ME, Miele L. A novel druggable target upstream of Notch: MEK5/ERK5 signaling regulates Jagged-1 and Notch1 expression in triple negative breast cancer stem cells [abstract]. In: Proceedings of the 2018 San Antonio Breast Cancer Symposium; 2018 Dec 4-8; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2019;79(4 Suppl):Abstract nr P2-03-04.

Abstract P5-08-07: Study of diphenylamine analogs as inducers of mesenchymal to epithelial transition in breast cancer

The organization of cell cytoskeleton is altered in events of epithelial to mesenchymal transition (EMT), promotion of cell motility, and cancer metastases. EMT is associated with decreased cell-cell adhesion, downregulation of epithelial markers like E-Cadherin, cytokeratins, and occludins, and upregulation of mesenchymal markers such as N-cadherin, vimentin, and various transcription factors such as slug and ZEB. Epithelial to mesenchymal transition is also a consequence of drug resistance and is responsible for cancer metastases. Triple negative breast cancer is highly aggressive cancer and patients show poor prognosis and disease-free survival due to the lack of targeted therapy. Mitogen activated protein kinase pathway, including extracellular activated kinase ERK1/2 and ERK5, and phosphoinositide 3-kinase (PI3K) pathway are known to alter the cytoskeleton through the downstream activation of oncogenes such as FRA-1 and loss of focal adhesions. Of these pathways, the MEK5-ERK5 pathway is understudied in triple negative breast cancer TNBC, and there are few research tools available to selectively inhibit this pathway. The diphenylamine analogs were derived from the parent molecule Mekinist, a FDA approved MEK1/2 inhibitor for melanoma, and modified to gain selectivity towards MEK5. SC-1-151, a type-III allosteric inhibitor of MEK5 is a dual MEK1/2 (98.6%) and MEK5 (59%) inhibitor; the molecule inhibits cell viability and colony formation, and attenuates tumor growth.

SC-1-151 was serendipitously identified as a mesenchymal to epithelial transition activator in TNBC cell line MDA-MB-231. E-cadherin protein expression and cell morphology were examined to study MET after the treatment of MDA-MB-231 cells with different structural analogs of SC-1-151 after treatment for 5 days. The compound was further found to induce E-cadherin expression and epithelial phenotype in tamoxifen resistant estrogen positive MCF-7 cell line that underwent EMT. The compound is identified to promote this activity by targeting at least the ERK-FRA1-ZEB1 axis. Alkyl or N-Methyl piperazine substituents on the amide of ring 1 produced similar result as SC-1-151, and substituting the amide group with acid or ester also induced MET. In contrast, ortho-fluoro, para-iodo functional groups of the arene ring 2, when replaced with a meta-bromo substituent did not induce MET. We aim to test the compounds on EGF treated MDA-MB-468 cells to observe the attenuation of EGF induced EMT. Future studies will be performed to determine the specific protein interactions of the promising compounds.

Citation Format: Bhatt AB, Wright TD, Anna K, Gupta M, Chakrabarty S, Flaherty PT, Hoang V, Burow M, Cavanaugh JE. Study of diphenylamine analogs as inducers of mesenchymal to epithelial transition in breast cancer [abstract]. In: Proceedings of the 2018 San Antonio Breast Cancer Symposium; 2018 Dec 4-8; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2019;79(4 Suppl):Abstract nr P5-08-07.

Abstract P3-07-19: Dual inhibition of the MEK5 and PI3K pathways synergistically reduces proliferation and viability in triple negative breast cancer cells

Aberrations in the MAPK/extracellular signal-regulated kinase (MEK/ERK) and phosphoinositide-3-kinase (PI3K) pathways have been linked to increased proliferation and survival in triple negative breast cancer (TNBC) cells. It has been proposed that these survival characteristics are enhanced through compensatory signaling and crosstalk mechanisms. Promising combinations of MEK and PI3K inhibition have been evaluated in phase I clinical trials for various cancer types. However, these clinical trials have had limited efficacy and have yet to encompass the MEK5/ERK5 pathway, which has been shown to promote cell survival. The goal of this study was to examine the crosstalk between the MEK1/2, MEK5, and PI3K pathways and determine the most promising combination of the MEK1/2, ERK5, and PI3K inhibitors, U0126, XMD8-92, and LY294002, respectively, in a diverse panel of triple negative breast cancer cell lines: BT549, MDA-MB-231, and MDA-MB-468. Our results indicate that dual inhibition of the MEK5 and PI3K pathways significantly reduced proliferation (45.53%) in MDA-MB-231 TNBC cells. Also, the combination of MEK5 and PI3K inhibition was shown to be synergistic. In contrast, inhibition of ERK1/2 alone or in combination with PI3K or ERK5 inhibition yielded mixed responses. Additionally, treatment with LY294004 in MDA-MB-231 (ERK 5 KO) was more potent (IC50= 2.5 uM) than treatment in the native MDA-MB-231 cell line (IC50= 13.7 uM). These data suggest that crosstalk between these kinases occurs and dual inhibition of PI3K and ERK5 may be a novel therapeutic approach for treating TNBC.

Citation Format: Wright TD, Raybuck C, Wendekier K, Cavanaugh JE. Dual inhibition of the MEK5 and PI3K pathways synergistically reduces proliferation and viability in triple negative breast cancer cells [abstract]. In: Proceedings of the 2016 San Antonio Breast Cancer Symposium; 2016 Dec 6-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2017;77(4 Suppl):Abstract nr P3-07-19.

Supramolecular structures of cadmium(II) coordination polymers: a new class of ligands formed by linking tripodal tris(pyrazolyl)methane units

The new ligands C(6)H(4)[CH(2)OCH(2)C(pz)(3)](2) (pz = pyrazolyl ring), 1 (ortho), 2 (meta), and 3 (para), that can potentially bond two or more metal centers were obtained in a single step from the reaction of the appropriate dibromoxylene, 2 equiv of tris-2,2,2-(1-pyrazolyl)ethanol, and excess NaH. Although the arrangement of the tris(pyrazolyl)methane units in the solid-state structures of 1 and 3 are similar, the orientation of these groups with respect to the phenyl ring are different, with 1 showing a twisted structure and 3 a stepped structure. The reaction of [Cd(2)(THF)(5)][BF(4)](4) with the appropriate ligand yields each of the three coordination polymers of the formula [C(6)H(4)[CH(2)OCH(2)C(pz)(3)](2)Cd](BF(4))(2)](n), 4 (ortho), 5 (meta), and 6 (para). In the solid-state structures of all three each tris(pyrazolyl)methane unit is tridentate, with each ligand bonded to two different cadmium(II) atoms, forming a coordination polymer containing 6-coordinate, pseudooctahedral cadmium(II) centers. Polymers 4 and 5 form wavelike chains whereas 6 is arranged in a stepped structure similar to the free ligand. The different connecting patterns of each ligand lead to very different supramolecular structures, structures organized by the BF(4)(-) groups through weak C-H...F hydrogen bonds. Crystallographic information: 1 is monoclinic, P2(1)/n, a = 16.3157(13) A, b = 8.5880(6) A, c = 21.9227(17) A, alpha = gamma = 90 degrees, beta = 100.134(2) degrees, Z = 4; 3 is monoclinic, P2(1)/n, a = 9.1965(9) A, b = 12.9185(12) A, c = 12.7306(12) A, alpha = gamma = 90 degrees, beta = 104.099(2) degrees, Z = 2; 4 is triclinic, P1, a = 10.7877(19) A, b = 12.582(2) A, c = 15.409(3) A, alpha =103.860(4) degrees, beta = 94.123(4) degrees, gamma = 92.573(4) degrees, Z = 2; 6 is monoclinic, C2/c, a = 23.023(3) A, b = 12.2588(14) A, c = 18.119(2) A, alpha = gamma = 90 degrees, beta = 121.281(2) degrees, Z = 4.

Control of the stereochemical impact of the lone pair in lead(II) tris(pyrazolyl)methane complexes. Improved preparation of Na[B[3,5-(CF3)2C6H3]4]

The reaction of Pb(acac)2 with 2 equiv of [H(Et2O)2][B[3,5-(CF3)2C6H3]4] (HBAr(f)) in CH2Cl2 followed by addition of 2 equiv of either HC(pz)3 or HC(3,5-Me2pz)3 (pz = pyrazolyl ring) leads to the formation of [Pb[HC(pz)3]2][B[3,5-(CF3)2C6H3]4]2 (1) and [Pb[HC(3,5-Me2pz)3]2][B[3,5-(CF3)2C6H3]4]2 (2), respectively. The cation in 1 has a distorted octahedral structure with a stereochemically active lone pair on lead(II). In contrast, the cation in 2 is trigonally distorted octahedral with the lone pair on the lead(II) clearly stereochemically inactive. The driving force for this cation to have a stereochemically inactive lone pair is that in this geometric arrangement the interligand distances between adjacent 3-position methyl groups are close to 4.0 A, the sum of the van der Waals radii of two methyl groups. To facilitate this chemistry, the synthesis of Na[B[3,5-(CF3)2C6H3]4], needed to prepare HBAr(f), has been dramatically improved. The main change is to add NaBF4 to the reaction mixture before forming the Grignard from the reaction of magnesium and 3,5-(CF3)2C6H3Br. The Grignard reacts with the NaBF4 as it forms, reducing the danger of explosion and leading to a higher isolated yield of the product. Crystallographic information: 1 is triclinic, P1, a = 13.0133(6) A, b = 17.2210(7) A, c = 24.7634(11) A, alpha = 71.7300(10) degrees, beta = 82.3630(10) degrees, gamma = 70.5120(10) degrees, Z = 2; 2 is triclinic, P1, a = 12.756(4) A, b = 13.469(4) A, c = 17.160(5) A, alpha = 82.454(7) degrees, beta = 89.904(8) degrees, gamma = 72.995(7) degrees, Z = 1.

A novel delta-subdivision proteobacterial lineage from the lower ocean surface layer

A small-subunit ribosomal RNA (16S rRNA) gene lineage (SAR324) affiliated with the delta-subdivision of the class Proteobacteria (DP) was discovered in a 16S rRNA gene clone library prepared from a water sample collected from 250 m in the western Sargasso Sea. This clone library of nearly full-length amplicons of bacterial 16S rRNA genes has been the subject of previous studies aimed at identifying bacteria that inhibit the lower ocean surface layer. The novel lineage was identified by randomly sequencing clones that did not hybridize to oligonucleotide probes specific for several abundant bacterioplankton groups identified in previous studies. Phylogenetic analysis indicated that SAR324 was most closely affiliated with the DP, although it showed no specific relationship to any DP 16S rRNA genes in databases. Eight of the clones in the library of 148 clones were identified as members of the SAR324 lineage by hybridization to an oligonucleotide probe specific for SAR324. Subsequent hybridizations showed that the SAR324 group is stratified in the lower surface layer of both the Atlantic and Pacific Oceans, with maxima between 160 and 500 m. The repeated discovery of sequences belonging to different gene clusters with similar distributions in this region of the water column suggests that microbial communities in the lower surface layer may be functionally specialized.

Effect of docking on health, blood cells and metabolites and growth of Dorset lambs

Docking by knife or elastrator had no sustained effect on growth of lambs 0 to 8 wk postpartum. However, during the 2 wk period postdocking, growth of lambs was limited or depressed, regardless of whether lambs were docked by knife at 14, 28 or 42 d of age. Blood hematocrit and hemoglobin were decreased (P less than .01) 1 d after docking by knife and 14 d after docking by elastrator. Neither method of docking proved superior. Regardless of whether lambs were docked by knife or elastrator, tail tissue was destroyed and became necrotic. Numbers of white blood cells increased (P less than .01) in response to docking. This necessitates that lambs be observed often through 2 wk postdocking and that medical treatment be administered when needed.